MAPT and Alzheimer disease: Subsequent studies have elucidated the neuroprotective roles of estrogen against AD-related pathology and have proposed that the beneficial effects of estrogen on AD are directly linked to its ability to reduce amyloid-β peptide and tau aggregates (Vest & Pike, 2013).